David James Reeves is a pharmacist who is specialized in Oncology in Detroit, Michigan. Patients can reach him at 4100 John R St, Detroit or contact him on 313-576-8806. Active license number of David James Reeves is 5302034556 for Oncology in Michigan. David James Reeves is a licensed pharmacist who has demonstrated specialized knowledge and skill in developing, recommending, implementing, monitoring, and modifying pharmacotherapeutic plans to optimize outcomes in patients with malignant diseases.
Complete Profile:
David James Reeves speciality, credentials, practice address, contact phone number and fax are as below. Patients can call on the below given phone number for enquiries.
Name:
David James Reeves
Specialization:
Oncology
Credentials:
PHARM.D.
Gender:
Male
Location:
4100 John R St, Detroit, Michigan, 48201-2013
Phone:
313-576-8806
Fax:
313-576-8811
Professional Identification Codes:
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS).
NPI details of David James Reeves are as mentioned below.
NPI Number:
1407025869
NPI Enumeration Date:
29 Feb, 2008
NPI Last Update On:
29 Feb, 2008
Medical Licenses:
Pharmacists can have one or more medical licenses for different specialities in the same state or different states. Related medical licenses for David James Reeves are as mentioned below.
Specialization
License Number
State
Status
Oncology
5302034556
Michigan
Primary
Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
Address:
4100 John R St, Detroit, Michigan
Zip:
48201-2013
Phone Number:
313-576-8806
Fax Number:
313-576-8811
Patients can reach David James Reeves at 4100 John R St, Detroit, Michigan or can call on phone at 313-576-8806.
Comments/ Reviews:
*Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 09 September, 2024.